Literature DB >> 15911839

Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors.

Catherine D De Angelis, Jeffrey M Drazen, Frank A Frizelle, Charlotte Haug, John Hoey, Richard Horton, Sheldon Kotzin, Christine Laine, Ana Marusić, A John P M Overbeke, Torben V Schroeder, Hal C Sox, Martin B Van Der Weyden.   

Abstract

Keywords:  Biomedical and Behavioral Research; International Committee of Medical Journal Editors

Mesh：

Year:  2005        PMID： 15911839      PMCID： PMC1150264          DOI： 10.1503/cmaj.050600

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  1 in total

1.  Clinical trial registration: a statement from the International Committee of Medical Journal Editors.

Authors:  Catherine De Angelis; Jeffrey M Drazen; Frank A Frizelle; Charlotte Haug; John Hoey; Richard Horton; Sheldon Kotzin; Christine Laine; Ana Marusic; A John P M Overbeke; Torben V Schroeder; Hal C Sox; Martin B Van Der Weyden
Journal:  CMAJ       Date:  2004-09-14       Impact factor: 8.262
  1 in total
  6 in total

1.  Why should clinical trials be registered?

Authors: 
Journal:  CMAJ       Date:  2005-06-21       Impact factor: 8.262

2.  Clarifying a misunderstanding on clinical trial registry.

Authors:  Deborah A Zarin
Journal:  CMAJ       Date:  2006-01-17       Impact factor: 8.262

3.  On bias and transparency in the development of influential recommendations.

Authors:  Andreas Laupacis
Journal:  CMAJ       Date:  2006-01-31       Impact factor: 8.262

4.  Is this clinical trial fully registered?

Authors:  Alain Braillon; Gérard Dubois
Journal:  CMAJ       Date:  2006-02-14       Impact factor: 8.262

5.  Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity?

Authors:  William L Lanier
Journal:  Mayo Clin Proc       Date:  2009-09       Impact factor: 7.616

6.  The quality of registration of clinical trials.

Authors:  Roderik F Viergever; Davina Ghersi
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.